“…These neuroendocrine lung tumors were comprised of invasively growing well differentiated cells that expressed the neuroendocrine markers serotonin, mammalian bombesin, calcitonin, and neuron-specific enolase, thus warranting a classification as neuroendocrine carcinomas in accordance with a recently established histological tumor classification for rodents (Nikitin, Alcaraz, Anver, Bronson, Cardiff, Dixon, Fraire, Gabrielson, Gunning, Haines, Kaufman, Linnoila, Maronpot, Rabson, Reddick, Rehm, Rozengurt, Schuller, Shmidt, Travis, Ward and Jacks, 2004). Similar to SCLC, the neuroendocrine lung tumors in hamsters did not harbor activating point mutations in k-ras while overexpressing c-myc (Miller, Baxter, Moore and Schuller, 1994). In analogy to our in vitro experiments (Jull, Plummer and Schuller, 2001), an inhibitor of PKC completely blocked the development of DEN-induced neuroendocrine lung carcinomas in hamsters with pulmonary fibrosis (Schuller, Correa, Orloff and Reznik, 1990).…”